$VSEC

VSE Corp (VSEC) Shares Fall 5.1% -- GF Value Says Still Overvalu

VSE Corp (VSEC) shares fell 5.1% to $178.08, down 26% in the past month. GF Value™ estimates the stock is 11.5% overvalued at $178.08 vs. $159.69. Insiders sold $5.5M in shares over 12 months. The GF Score™ is 83/100, with strong growth but weak financial strength and profitability.

Original reporting
Published Sep 15, 2026, 11:26 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 16, 2026, 7:50 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$VSEC
Bearish
medium confidence
Mentioned
$VSEC
Relevance
4/10
AlphAI data visualization · based on gurufocus.com
Decision brief

The 30-second read

$VSECBearishLow
01

Why it matters

The article reiterates existing valuation metrics without new material events, offering limited actionable insight.

02

Market read

Primarily a stock‑specific price‑move commentary with little broader market impact.

03

What to watch

Recent contract wins or pipeline developments not covered in the article could offset valuation concerns.

Relevance 4/10Novelty 2/10Timing: after market close on Sep 15, 2026

Background

GuruFocus valuation analysis highlights a 5.1% price drop and insider selling, framing VSEC as modestly overvalued.

Company-level read

Ticker impact

$VSECBearishMedium confidence
Context

Shares fell 5.1% to $178.08 on Sep 15, 2026, with insiders selling $5.5M of stock and the GF valuation indicating the company is overvalued.

Expected impact

Further downside pressure likely if insider selling continues and valuation concerns persist.

Evidence & confidence

The article provides no new catalyst beyond price move and valuation commentary; the downside bias is supported by insider sell data.

Market effects

Valuation concerns may affect peer industrials with similar growth profiles.

Limited to U.S. small‑cap investors tracking VSEC.

Minimal; no broader macro or sector shock.

Counterpoint

The stock could be undervalued relative to its growth potential if the forward P/E of 22.8x materializes.

Key entities

  • VSE Corp

    Publicly listed U.S. company (ticker VSEC) under valuation scrutiny.

Related articles

$VSECMed

Guggenheim initiates VSE stock with neutral on margin concerns

Guggenheim initiated VSE Corporation (VSEC) with a neutral rating, citing margin concerns and the need for operational improvements. The company reported Q2 2026 earnings of $1.75 per share on $449.1M revenue, beating estimates. Stifel raised its price target to $260, maintaining a Buy rating. VSEC's EBITDA grew 98% YoY to $86M, with margins expanding to 19.2%.

$VSECMedAI 8/10

A Record Quarter Raises The Stakes For VSE Corp. (VSEC)

VSE Corporation (VSEC) reported Q2 revenue of $449.1M, up 65% YoY, with organic growth of 14%. Adjusted EBITDA rose to $86.0M, with a margin of 19.2%. The company completed two major acquisitions, raising full-year guidance. Debt increased to $966.7M, and free cash flow was negative $50.0M for H1 2026. The stock trades at 25x forward earnings.

$VSECMed

VSE (VSEC) Q2 2026 Earnings Call Transcript

VSE Corp (VSEC) Q2 2026 earnings call said it delivered record revenue and profitability. Revenue rose to $449 million, up 65% YoY, with 14% organic growth. Adjusted EBITDA was $86 million, up 98% YoY, and margin reached a record 19.2%. VSE said it closed the PAG deal May 5 (~$2B) and NorthStar on April 1, and raised full-year revenue and margin guidance.